Can childhood trauma be prevented with a drug?

A recent study led by researchers in Munich and Stockholm has explored whether a drug could prevent childhood trauma from taking hold. The researchers began by creating an environment of hardship for mother mice, leading to erratic behavior and unpredictable early life experiences for their offspring. Despite appearing healthy, these mice later exhibited an inability to establish their social position, suggesting early adversity had a lasting impact.

The researchers then administered a drug called SAFit2, which blocks a protein called FKBP51, to some of the mice during the stressful period. This intervention allowed the treated mice to perform as well as those raised without hardship, effectively erasing the social cost of a difficult start in life. The drug worked by reversing the physiological effects of early adversity, particularly in brain regions involved in emotional control and reward.

However, the study's findings are still preliminary, as prevention only works if risk can be identified beforehand, and SAFit2 is still a research compound that has not yet been tested for safety in humans. Nonetheless, the research offers hope for a more targeted approach to treating stress-related disorders, potentially allowing for intervention before long-lasting damage occurs.